Alexander Maxwell
Value, growth, long-term horizon, biotech

Ardelyx: A Promising IPO

For investors interested in the biotechnology industry, we must keep up to date with not only a lot of the new drugs that are coming out for established companies, but we must also keep up to date with companies that are having IPOs. This is important so that we may be able to find value in companies that are just beginning to be traded on the stock market. One such company is Ardelyx (NASDAQ:ARDX), which will begin trading on Thursday. Ardelyx represents a compelling opportunity for investors, and represents a compelling risk/reward for long term oriented investors. Ardelyx has a deep pipeline partnered with some of the largest pharmaceutical companies in the world, which will allow for the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details